Sermonix Pharmaceuticals
Columbus, United States · $66.0M raised
- Headquarters
- Columbus
- Website
- sermonixpharma.com
- Total Funding
- $66.0M
- Last Round
- $40.0M Venture RoundNov 2021
- Rounds
- 2
About
Sermonix Pharmaceuticals is a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC). The company's lead candidate, lasofoxifene, is being evaluated as a neoadjuvant endocrine therapy in molecularly selected HR+/HER2-, locally advanced breast cancer in a Phase 2 trial with Quantum Leap Healthcare Collaborative, and has shown promising early activity in suppressing the Ki67 protein in both premenopausal and postmenopausal patients.
Summary
Sermonix Pharmaceuticals is a Biotech company based in Columbus, United States. It has raised $66.0M in total across 2 rounds, most recently a $40.0M Venture Round round in Nov 2021. Investors include Wild Family Office.
Funding History
Nov 2021
Sign up to see all 2 rounds
Series A through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Therapeutics company working in drug discovery and development using fungi with genomics approach...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sermonix-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/sermonix-pharmaceuticals" alt="Sermonix Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>